Astrocyte

CURRENT STRATEGIES IN STROKE THERAPY: TEMPORALITY, PHARMACOLOGICAL AGENTS AND ENDOVASCULAR TREATMENTS
Year
: 2018  |  Volume : 5  |  Issue : 1  |  Page : 33--38

Current strategies in stroke therapy: Temporality, pharmacological agents and endovascular treatments


Yunis Mayasi1, Brian Silver2 
1 Division of Neurosciences Critical Care, Department of Anesthesia and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA
2 Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA

Correspondence Address:
Brian Silver
Department of Neurology, University of Massachusetts Medical School, 55 Lake Ave, North Worcester, MA 01655
USA

Stroke, a leading cause of morbidity and mortality, remains an active venue for discovery. Advances in stroke neurology include prevention, treatment, and detection, in addition to rehabilitation. In terms of treatment, vast strides have been taken since the five major intra-arterial treatment trials, with extension of the treatment window in addition to the use of imaging for better patient selection. Treatment of hemorrhagic stroke has also improved in the past decade with better understanding of the pathophysiology of the disease, establishment of guidelines for blood pressure control and monitoring, treatment of coagulopathies in addition to surgical interventions. Several ongoing trials are being conducted to further elucidate the utility and efficacy of minimally invasive surgical options in deep intracranial hemorrhage.


How to cite this article:
Mayasi Y, Silver B. Current strategies in stroke therapy: Temporality, pharmacological agents and endovascular treatments.Astrocyte 2018;5:33-38


How to cite this URL:
Mayasi Y, Silver B. Current strategies in stroke therapy: Temporality, pharmacological agents and endovascular treatments. Astrocyte [serial online] 2018 [cited 2021 Oct 22 ];5:33-38
Available from: http://www.astrocyte.in/article.asp?issn=2349-0977;year=2018;volume=5;issue=1;spage=33;epage=38;aulast=Mayasi;type=0